Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 single-arm study of albumin-bound paclitaxel plus cisplatin with concurrent chemoradiotherapy for locally advanced cervical cancer
ChiCTR2000033027Phase 2Recruiting
- Sponsor
- Affiliated Cancer Hospital of Guangzhou Medical University
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel and cisplatin in Cervical Cancer (CC), sponsored by Affiliated Cancer Hospital of Guangzhou Medical University. Primary endpoint: Objective response rate. Started May 2020; status: recruiting.
02
Drugs
paclitaxelcisplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on ChiCTR2000033027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033027.